Published in Eur J Nucl Med Mol Imaging on July 09, 2005
The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging (2013) 2.25
The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol (2007) 1.24
Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat (2012) 1.10
A further survey of surgical management of the axilla in UK breast cancer patients. Ann R Coll Surg Engl (2010) 1.09
Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging (2010) 1.02
Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation? Eur J Nucl Med Mol Imaging (2009) 0.94
Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer (2012) 0.93
Sentinel node mapping for breast cancer: current situation. J Oncol (2012) 0.86
Medial tumor localization in breast cancer--an unappreciated risk factor? Strahlenther Onkol (2009) 0.81
Main controversies in breast cancer. World J Clin Oncol (2014) 0.80
The orderly progression of melanoma nodal metastases. Ann Surg (1994) 2.16
Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol (2003) 2.06
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg (2001) 1.79
Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys (2000) 1.71
Lymphatic drainage patterns from the breast. Ann Surg (2004) 1.53
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg (2001) 1.38
Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg (2002) 1.32
Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol (2000) 1.22
Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol (2002) 1.17
Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med (2005) 0.99
Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med (2002) 0.99
Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg (2000) 0.96
Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys (2004) 0.93
Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol (2001) 0.88
Current controversies in sentinel lymph node biopsy for breast cancer. Breast (2003) 0.85
Controversial topics in breast lymphatic mapping. Semin Oncol (2004) 0.76
Nuclear medicine aspects of melanoma and breast lymphatic mapping. Semin Oncol (2004) 0.76
Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol (2004) 0.76
Impact of internal mammary sentinel node imaging in breast cancer. Clin Nucl Med (2003) 0.75
[Comparative study of the different radiotracer administration route to locate the sentinel node in breast cancer]. Rev Esp Med Nucl (2004) 0.75
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol (2010) 3.15
Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging (2014) 2.06
Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol (2003) 2.06
Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol (2008) 1.83
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. Int J Radiat Oncol Biol Phys (2010) 1.58
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases. Tumour Biol (2011) 1.50
High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing. Am J Obstet Gynecol (2007) 1.46
Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging (2006) 1.46
Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem (2011) 1.30
2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging (2009) 1.24
18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging (2009) 1.20
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum (2008) 1.18
Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol (2006) 1.05
Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol (2005) 1.01
SPECT-CT and real-time intraoperative imaging: new tools for sentinel node localization and radioguided surgery? Eur J Nucl Med Mol Imaging (2009) 1.00
Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages. Int J Radiat Oncol Biol Phys (2002) 0.99
Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value. Tumour Biol (2010) 0.96
Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging (2004) 0.96
Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology (2010) 0.95
Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes? Eur J Nucl Med Mol Imaging (2002) 0.95
The European board of nuclear medicine fellowship examination. Eur J Nucl Med Mol Imaging (2006) 0.95
Radiologic and pathologic findings in breast tumors with high signal intensity on T2-weighted MR images. Radiographics (2010) 0.94
Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum (2002) 0.94
MRI of metaplastic carcinoma of the breast. AJR Am J Roentgenol (2005) 0.93
Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys (2004) 0.93
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging (2013) 0.93
Technological innovation in the sentinel node procedure: towards 3-D intraoperative imaging. Eur J Nucl Med Mol Imaging (2010) 0.91
Ultrasound-anatomic correlation of the peripheral nerves of the upper limb. Surg Radiol Anat (2009) 0.90
Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? Gynecol Oncol (2011) 0.89
Transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR): a new method for sentinel lymph node detection in endometrial cancer. Gynecol Oncol (2012) 0.88
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol (2003) 0.87
Bone mineral density in male adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry (2002) 0.87
Assessing myometrial infiltration by endometrial cancer: uterine virtual navigation with three-dimensional US. Radiology (2009) 0.87
Added value of intraoperative real-time imaging in searches for difficult-to-locate sentinel nodes. J Nucl Med (2010) 0.86
Usefulness of 99mTc-ciprofloxacin scintigraphy in the diagnosis of prosthetic joint infections. Nucl Med Commun (2011) 0.86
Is sphere assay useful for the identification of cancer initiating cells of the ovary? Int J Gynecol Cancer (2015) 0.86
Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer. Clin Chem (2010) 0.86
Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept. Eur J Nucl Med Mol Imaging (2012) 0.86
Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren's syndrome. J Rheumatol (2010) 0.85
Power Doppler sonography of invasive breast carcinoma: does tumor vascularization contribute to prediction of axillary status? Radiology (2004) 0.84
Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent. Breast (2007) 0.83
CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. Anticancer Res (2005) 0.83
Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ. Breast J (2013) 0.82
MRI signal changes of the bone marrow in HIV-infected patients with lipodystrophy: correlation with clinical parameters. Skeletal Radiol (2011) 0.82
Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy. Epilepsia (2011) 0.82
A prospective study comparing whole-body FDG PET/CT to combined planar bone scan with 67Ga SPECT/CT in the Diagnosis of Spondylodiskitis. Clin Nucl Med (2012) 0.81
Predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement: evaluation of two scoring systems. Breast J (2010) 0.81
Validation of an automatic dose injection system for Ictal SPECT in epilepsy. J Nucl Med (2012) 0.81
SPECT-CT and intraoperative portable gamma-camera detection protocol for sentinel lymph node biopsy in oral cavity squamous cell carcinoma. J Craniomaxillofac Surg (2015) 0.81
Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians. Melanoma Res (2017) 0.80
Pathologic prognostic factors in stage I-III uterine carcinosarcoma treated with postoperative radiotherapy. Arch Gynecol Obstet (2014) 0.80
High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. J Bone Miner Metab (2009) 0.80
Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Eur J Nucl Med Mol Imaging (2011) 0.80
Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16(INK4A) overexpression and clinicopathological correlations. Histopathology (2010) 0.80
Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina. Gynecol Oncol (2012) 0.80
A practical approach to intraoperative evaluation of sentinel lymph node biopsy in breast carcinoma and review of the current methods. Ann Surg Oncol (2005) 0.80
Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging (2006) 0.80
Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement? BJU Int (2012) 0.80
Temporomandibular joint soft-tissue pathology, II: Nondisc abnormalities. Semin Ultrasound CT MR (2007) 0.79
Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients. Melanoma Res (2004) 0.79
Is there a role for PET/CT with esophagogastric junction adenocarcinoma? Clin Nucl Med (2015) 0.79
Clinical role of cervical cancer vaccination: when and whom to vaccinate? Gynecol Oncol (2008) 0.79
Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT. Nucl Med Commun (2014) 0.79
Portable gamma cameras: the real value of an additional view in the operating theatre. Eur J Nucl Med Mol Imaging (2011) 0.79
Left ventricular function and visual phase analysis with equilibrium radionuclide angiography in patients with biventricular device. Eur J Nucl Med Mol Imaging (2008) 0.78
Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. Liver Int (2007) 0.78
The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging (2014) 0.78
How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component? Clin Transl Oncol (2009) 0.78
Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma. Clin Transl Oncol (2009) 0.78
Laparoscopic lymphadenectomy in advanced cervical cancer: prognostic and therapeutic value. Int J Gynecol Cancer (2013) 0.77
[The value of positron emission tomography/computed tomography (PET/CT) in the staging of diffuse large B-cell lymphoma]. Med Clin (Barc) (2007) 0.77
Selective sentinel lymph node biopsy and primary systemic therapy in breast cancer. Tumori (2010) 0.77
Histological transformation of follicular lymphoma after treatment: a case evaluated with PET/CT. Clin Nucl Med (2009) 0.77
Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine. Int J Cancer (2003) 0.77